Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases. The company provides a proprietary rare disease platform based on the company's real-world data. The company's platform includes epidemiologic, phenotypic and genetic data that reflects a global population, and also a biobank of patients' blood samples. The company's goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using the company's knowledge of the global rare disease market, including epidemiological and clinical data and biomarkers.